Publication | Open Access
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
158
Citations
17
References
2018
Year
High GPC1 crExos may be able to determine PDAC tumor size and disease burden. However, further efforts are needed to elucidate its role as a diagnostic and/or prognostic biomarker using larger cohorts of PDAC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1